Real-time enrollment status for this acute myeloid leukemia (aml) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 3:04 PM UTC
| NCT Number | NCT05188170 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia (AML) |
| Phase | PHASE1 |
| Target Enrollment | 16 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Stanford University |
| Last Updated on CT.gov | August 12, 2026 (2 weeks ago) |
As of August 28, 2026: Clinical trial NCT05188170 is currently recruiting participants. This phase1 study for acute myeloid leukemia (aml) is actively seeking new participants at 1 location across the United States. The study is sponsored by Stanford University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05188170 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05188170 was last updated 2 weeks ago (August 12, 2026). HelloStudys verifies this status automatically.